Írország - angol - HPRA (Health Products Regulatory Authority)

stallergenes - dermatophagoides pteronyssinus extract; dermatophagoides farinae extract - sublingual tablet - 300 index of reactivity - house dust mites

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - dermatophagoides farinae allergen extract 6 sq-hdm; dermatophagoides pteronyssinus allergen extract 6 sq-hdm - sublingual tablet - 12 sq-hdm - active: dermatophagoides farinae allergen extract 6 sq-hdm dermatophagoides pteronyssinus allergen extract 6 sq-hdm excipient: gelatin mannitol sodium hydroxide - acarizax is indicated for the treatment of adults diagnosed with: - house dust mite (hdm) allergic rhinitis (ar) not well controlled despite use of symptom relieving medication or - hdm allergic asthma (aa) not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis. patients' asthma status should be carefully evaluated before the initiation of treatment.

Egyesült Államok - angol - NLM (National Library of Medicine)

alk-abello, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k) - dermatophagoides farinae 10000 [au] in 1 ml - this product is indicated for the diagnosis and treatment of hypersensitivity in patients with symptoms compatible with dust mite allergy. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. mixtures of standardized mite (d. farinae and d. pteronyssinus) should be considered for treatment of patients who are sensitive to both species. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. there are no known absolute contraindications to immunotherapy. however, a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms and positive skin tests. in most case

Kanada - angol - Health Canada

alk-abello a/s - dermatophagoides pteronyssinus; dermatophagoides farinae - tablet - 6unit; 6unit - dermatophagoides pteronyssinus 6unit; dermatophagoides farinae 6unit - allergenic extracts

Kanada - angol - Health Canada

allergologisk lab a/s - dermatophagoides pteronyssinus - liquid - 10000unit - dermatophagoides pteronyssinus 10000unit - allergenic extracts

Kanada - angol - Health Canada

alk-abello inc - dermatophagoides pteronyssinus - liquid - 10000unit - dermatophagoides pteronyssinus 10000unit - allergenic extracts

Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

stallergènes s.a. - dermatophagoides farinae, allergens 50 ir (tablet 100 ir); dermatophagoides pteronyssinus, allergens 50 ir (tablet 100 ir); dermatophagoides farinae, allergens 150 ir (tablet 300 ir); dermatophagoides pteronyssinus, allergens 150 ir (tablet 300 ir) - sublingual tablet - 100 ir - 300 ir - dermatophagoides farinae, allergens 50 ir; dermatophagoides pteronyssinus, allergens 50 ir; dermatophagoides farinae, allergens 150 ir; dermatophagoides pteronyssinus, allergens 150 ir - house dust mites

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata; triticum aestivum; olea europaea; european house dust mite extract; american house dust mite extract; dermatophagoides pteronyssinus body extract; dermatophagoides farinae body extract; lolium perenne; phleum pratense; dactylis glomerata; anthoxanthum odoratum; poa pratensis; cynodon dactylon; mannitol; arrhenatherum elatius; holcus lanatus; avena fatua; bromus inermis; agrostis tenuis; festuca elatior; holcus latanus; cynodon dactylon pollen extract; dermatophagoides farinae body extra -

Egyesült Államok - angol - NLM (National Library of Medicine)

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), juniperus virginiana pollen (unii: py0ja16r2g) - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

Egyesült Államok - angol - NLM (National Library of Medicine)

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), juglans nigra pollen (unii: 1bv28146zr) (juglans nigra pollen - unii:1bv28146zr), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense p - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski